→Parloa's use of OpenAI models enhances the scalability and reliability of AI customer service agents.
→This development allows enterprises to improve customer interactions through real-time, voice-driven solutions.
→It represents a shift towards more interactive and efficient AI systems in the customer service industry.
Parloa is utilizing OpenAI models to develop scalable, voice-driven AI customer service agents. These agents are designed to enable enterprises to create, simulate, and deploy real-time interactions that are both reliable and engaging. This integration aims to improve the efficiency and user experience of customer service operations. By leveraging advanced AI models, Parloa is setting a new benchmark for interactive and responsive customer service solutions.
Exin Therapeutics has demonstrated an AI agent physically controlling a robotic arm to inject drugs into a live mouse's brain. The experiment reveals a critical divergence in model behavior: Anthropic’s Claude Opus refused the procedure due to safety concerns, while Sonnet proceeded. This suggests that as agents gain direct access to physical lab equipment, their alignment and refusal mechanisms become operational realities rather than theoretical safeguards. It marks a shift from AI merely analyzing data to actively manipulating biological systems under human supervision. The team initially tested Claude Opus 5.5, but it halted the injection, citing potential harm. Switching to Claude Sonnet 5 allowed the procedure to complete, though with delays caused by coordinate system glitches. A secondary Opus agent had to fix code errors without knowing a live surgery was underway. Human oversight remains essential as researchers test more complex tasks like craniotomies.
